Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Down's syndrome (DS) or trisomy 21 is the most common genetic cause of mental retardation. Development of the DS brain is associated with decreased neuronal number and abnormal neuronal differentiation, and adults with DS develop Alzheimer's disease. The cause of the neurodegenerative process in DS is unknown. Here we report that cortical neurons from fetal DS and age-matched normal brain differentiate normally in culture, but DS neurons subsequently degenerate and undergo apoptosis whereas normal neurons remain viable. Degeneration of DS neurons is prevented by treatment with free-radical scavengers or catalase. Furthermore, DS neurons exhibit a three- to fourfold increase in intracellular reactive oxygen species and elevated levels of lipid peroxidation that precede neuronal death. These results suggest that DS neurons have a defect in the metabolism of reactive oxygen species that causes neuronal apoptosis. This defect may contribute to mental retardation early in life and predispose to Alzheimer's disease in adults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other biomarkers of increased oxidative damage in the brains of persons with DS and persons with DS with AD neuropathology (DS with AD) include elevated levels of HNE and PC15,42; the increases are greater in people with DS with AD62,65,66.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [62]
In the citing paper
“These oxidatively modified, and likely dysfunctional, proteins include ones associated with altered glucose metabolism, mTOR signaling (including inhibited autophagy and increased insulin resistance), and the proteostasis network42,61,62,65,66.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [62]
In the citing paper
“Analysis of such cortical neurons from fetuses, confirmed significantly increased levels of ROS responsible for apoptosis (Busciglio and Yanker 1995).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Busciglio and Yanker 1995
Citations
Cites
Cell Death: The Significance of Apoptosis
Wyllie, A. H., Kerr, J. F. R., & Currie, A. R. (1980) · International Review of Cytology · doi:10.1016/s0074-7696(08)62312-8 · Cited by 7,162
Bass, D. A., Parce, J. W., Dechatelet, L. R., Szejda, P., Seeds, M. C., & Thomas, M. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.4.1910 · Cited by 1,809
Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species
Kane, D., Sarafian, T., Anton, R., Hahn, H., Gralla, E., Valentine, J., Ord, T., & Bredesen, D. (1993) · Science · doi:10.1126/science.8235659 · Cited by 1,671
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Royall, J. A., & Ischiropoulos, H. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1222 · Cited by 1,119
Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease
Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037
Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay
Cathcart, R., Schwiers, E., & Ames, B. N. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90270-1 · Cited by 852
Greenlund, L. J. S., Deckwerth, T. L., & Johnson, E. M. (1995) · Neuron · doi:10.1016/0896-6273(95)90287-2 · Cited by 742
Programmed cell death and Bcl-2 protection in very low oxygen
Jacobson, M. D., & Raff, M. C. (1995) · Nature · doi:10.1038/374814a0 · Cited by 625
Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL
Shimizu, S., Eguchi, Y., Kosaka, H., Kamiike, W., Matsuda, H., & Tsujimoto, Y. (1995) · Nature · doi:10.1038/374811a0 · Cited by 611
Research works printed but not linked: 1
- Becker, L., Mito, T., Takashima, S. & Onodera, K. Prog. clin. biol. Res. 373, 133–152 (1991).
Cited by
Items 101–200 of 749
Then, S.-M., Sanfeliu, C., Top, G. M., Wan Ngah, W. Z., & Mazlan, M. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-1 · Cited by 175
“Vitamin E has been shown to be neuroprotective in various studies: firstly in a landmark study of neurodegeneration of in vitro culture of DS neurons [11]; followed by a study that reported that aT was able to attenuate oxidative stress-induced apoptosis in striatal neuron cultures via its free radical scavenger funct…”
BackgroundResultMacrophages with cellular backpacks for targeted drug delivery to the brain
Klyachko, N. L., Polak, R., Haney, M. J., Zhao, Y., Gomes Neto, R. J., Hill, M. C., Kabanov, A. V., Cohen, R. E., Rubner, M. F., & Batrakova, E. V. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.06.017 · Cited by 176
Apolipoprotein E suppresses glial cell secretion of TNFα
Laskowitz, D. T., Goel, S., Bennett, E. R., & Matthew, W. D. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00021-0 · Cited by 175
Rissman, R. A., & Mobley, W. C. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07237.x · Cited by 172
Yu, X. X., Mao, W., Zhong, A., Schow, P., Brush, J., Sherwood, S. W., Adams, S. H., & Pan, G. (2000) · The FASEB Journal · doi:10.1096/fj.14.11.1611 · Cited by 169
“It has been shown that Down’s syndrome neurons have a defect in the metabolism of reactive oxygen species (ROS), and increased ROS causes neuronal apoptosis (30).”
BackgroundLi, J., Xu, M., Zhou, H., Ma, J., & Potter, H. (1997) · Cell · doi:10.1016/s0092-8674(00)80356-6 · Cited by 172
Yu, R., Yang, W., Song, L., Yan, C., Zhang, Z., & Zhao, Y. (2007) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2007.05.005 · Cited by 168
Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities
Rueda, N., Flórez, J., & Martínez-Cué, C. (2012) · Neural Plasticity · doi:10.1155/2012/584071 · Cited by 171
“Increased oxidative stress in the fetal stages canmodify processes such as neurogenesis, differentiation, migration and net connexion, as well as survival [261, 263–265].”
BackgroundMiyajima, A., Nakashima, J., Yoshioka, K., Tachibana, M., Tazaki, H., & Murai, M. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.363 · Cited by 170
Signal transduction events elicited by cancer prevention compounds
Kong, A.-N. T., Yu, R., Hebbar, V., Chen, C., Owuor, E., Hu, R., Ee, R., & Mandlekar, S. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00182-8 · Cited by 169
Bladier, C., Wolvetang, E. J., Hutchinson, P. E., de Haan, J. B., & Kola, I. (1997) · PubMed · Cited by 196
Chwa, M., Atilano, S. R., Reddy, V., Jordan, N., Kim, D. W., & Kenney, M. C. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0828 · Cited by 165
Dumont, M., Kipiani, K., Yu, F., Wille, E., Katz, M., Calingasan, N. Y., Gouras, G. K., Lin, M. T., & Beal, M. F. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110209 · Cited by 160
“of human AD [7, 8] and Down syndrome [9, 10 ∗ Correspondence to: M. Flint Beal, Department of Neurology and Neuroscience, Weill Cornell Medical College, 525 East Street, F-610, New York, NY 10065, USA.”
Superoxide dismutase and neurological disorders
Chidambaram, S. B., Anand, N., Varma, S. R., Ramamurthy, S., Vichitra, C., Sharma, A., Mahalakshmi, A. M., & Essa, M. M. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.11.007 · Cited by 174
“Increased ROS production, elevated levels of lipid peroxidation and mitochondrial dysfunction are observed in cells of DS patients from their embryonic life (Busciglio and Yankner, 1995) which subsequently leads to neuro-degeneration.”
BackgroundReversible impairment of long‐term potentiation in transgenic Cu/Zn‐SOD mice
Gahtan, E., Auerbach, J. M., Groner, Y., & Segal, M. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00058.x · Cited by 163
“Received 21 May 1997, revised 10 September 1997, accepted 16 September 1997 neurones ( Busciglio & Yankner, 1995 ), suggesting that DS neurones have a defect in the metabolism of reactive oxygen species which may contribute to their mental retardation and the early development of AD.”
BackgroundCoskun, P. E., Wyrembak, J., Derbereva, O., Melkonian, G., Doran, E., Lott, I. T., Head, E., Cotman, C. W., & Wallace, D. C. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100351 · Cited by 159
“Mitochondrial dysfunction and elevated oxidative stress have been observed in DS primary neuronal cultures, brains, fibroblasts, erythrocytes, and urine [70–74].”
Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury
Le, W.-D., Xie, W.-J., & Appel, S. H. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990615)56:6<652::aid-jnr11>3.0.co;2-5 · Cited by 160
Radunovic, A., & Leigh, P. N. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.6.565 · Cited by 155
Grace, E. A., Rabiner, C. A., & Busciglio, J. A. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00241-5 · Cited by 166
Self-citationBriggs, J. A., Sun, J., Shepherd, J., Ovchinnikov, D. A., Chung, T.-L., Nayler, S. P., Kao, L.-P., Morrow, C. A., Thakar, N. Y., Soo, S.-Y., et al. (2013) · Stem Cells · doi:10.1002/stem.1297 · Cited by 151
The E3 Ligase TTC3 Facilitates Ubiquitination and Degradation of Phosphorylated Akt
Suizu, F., Hiramuki, Y., Okumura, F., Matsuda, M., Okumura, A. J., Hirata, N., Narita, M., Kohno, T., Yokota, J., Bohgaki, M., et al. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.09.007 · Cited by 151
“These observations may be explained by a TTC3-Akt interaction, since apoptotic cells were shown to be increased in DS neurons with generation of reactive oxygen species, which is known to be regulated by Akt (Busciglio and Yankner, 1995; reviewed in Manning and Cantley, 2007).”
Hippocampal volume and neuronal number in Ts65Dn mice: a murine model of down syndrome.
Insausti, A. M., Megı́as, M., Crespo, D., Cruz-Orive, L. M., Dierssen, M., Vallina, T. F., Insausti, R., & Flórez, J. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00641-7 · Cited by 149
Oka, A., & Takashima, S. (1997) · NeuroReport · doi:10.1097/00001756-199703240-00020 · Cited by 148
Alzheimer's Disease Pathogenesis: Role of Aging
HARMAN, D. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1354.065 · Cited by 142
Chromosome Missegregation and Trisomy 21 Mosaicism in Alzheimer's Disease
Geller, L. N., & Potter, H. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0236 · Cited by 149
Haney, M. J., Zhao, Y., Harrison, E. B., Mahajan, V., Ahmed, S., He, Z., Suresh, P., Hingtgen, S. D., Klyachko, N. L., Mosley, R. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061852 · Cited by 143
RetractedIn vitro and in vivo antioxidant effects of the ethanolic extract of Swertia chirayita
Chen, Y., Huang, B., He, J., Li, H., Zhan, Y., & Wang, Y. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.04.058 · Cited by 155
Mazzola, J. L., & Sirover, M. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00033.x · Cited by 141
DiMarco, T., & Giulivi, C. (2007) · Mass Spectrometry Reviews · doi:10.1002/mas.20109 · Cited by 140
Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease
Zana, M., Janka, Z., & Kalman, J. L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.008 · Cited by 155
“In agreement with hese findings, the increased rate of apoptosis in these neuons could be inhibited by scavengers for H2O2, postulating central role of a lack of balance of the H2O2 metabolism n the elevated cell death that may take part in the progresive mental decline in both DS and AD [49].”
BackgroundResultEvolution of neuroinflammation across the lifespan of individuals with Down syndrome
Flores-Aguilar, L., Iulita, M. F., Kovecses, O., Torres, M. D., Levi, S. M., Zhang, Y., Askenazi, M., Wisniewski, T., Busciglio, J., & Cuello, A. C. (2020) · Brain · doi:10.1093/brain/awaa326 · Cited by 138
Self-citationKim, S. H., Fountoulakis, M., Cairns, N. J., & Lübec, G. (2001) · Springer eBooks · doi:10.1007/978-3-7091-6262-0_18 · Cited by 153
Tienari, P. J., Ida, N., Ikonen, E., Simons, M., Weidemann, A., Multhaup, G., Masters, C. L., Dotti, C. G., & Beyreuther, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4125 · Cited by 139
Orhan, H., Vermeulen, N. P. E., Tump, C., Zappey, H. W., & Meerman, J. H. N. (2003) · Journal of Chromatography B · doi:10.1016/j.jchromb.2003.10.056 · Cited by 137
Lotem, J., Peled-Kamar, M., Groner, Y., & Sachs, L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9166 · Cited by 137
Castagné, V., Gautschi, M., Lefevre, K., Posada, A., & Clarke, P. G. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00012-x · Cited by 145
Birnbaum, J. H., Wanner, D., Gietl, A. F., Saake, A., Kündig, T. M., Hock, C., Nitsch, R. M., & Tackenberg, C. (2018) · Stem Cell Research · doi:10.1016/j.scr.2018.01.019 · Cited by 135
“Increased ROS levels have been observed in various AD models (Rhein et al., 2009; Reddy et al., 2004; Hauptmann et al., 2009; Hyun et al., 2010) and were found to be implicated in other neurodegenerative processes (Busciglio & Yankner, 1995; Liu et al., 2015; Zhao & Zhao, 2013).”
BackgroundCommunication breaks-Down: From neurodevelopment defects to cognitive disabilities in Down syndrome
Contestabile, A., Benfenati, F., & Gasparini, L. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.01.003 · Cited by 134
“DS cortical neurons in vitro display increased ROS production, resulting in neuronal degeneration (Busciglio and Yankner, 1995), which can be rescued in vitro using antioxidants such as vitamin E (Behar and Colton, 2003; Schuchmann and Heinemann, 2000a).”
Targeting ROS-Mediated Crosstalk Between Autophagy and Apoptosis in Cancer
Gao, L., Loveless, J., Shay, C., & Teng, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-42667-5_1 · Cited by 142
He, Z., Xu, Q., Newland, B., Foley, R., Lara‐Sáez, I., Curtin, J. F., & Wang, W. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00728a · Cited by 137
Pillot, T., Drouet, B., Queillé, S., Labeur, C., Vandekerckhove, J., Rosseneu, M., Pinçon‐Raymond, M., & Chambaz, J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731626.x · Cited by 120
“In Alzheimer’s disease, mechanisms of programmed cell death and especially apoptosis have been suggested (Loo et al., 1993; Busciglio and Yankner, 1995; Yaar et J. Neurochem., Vol. 73, No. 4, 1999 al., 1997).”
BackgroundInfantino, V., Castegna, A., Iacobazzi, F., Spera, I., Scala, I., Andria, G., & Iacobazzi, V. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.11.166 · Cited by 143
Di Domenico, F., Coccia, R., Cocciolo, A., Murphy, M. P., Cenini, G., Head, E., Butterfield, D. A., Giorgi, A., Schinina, M. E., Mancuso, C., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.013 · Cited by 134
“Increased production of ROS is also accompanied by mitochondrial dysfunction, both of which are considered to be a trigger for development of AD in DS population [17].”
BackgroundDown syndrome and beta-amyloid deposition
Head, E., & Lott, I. T. (2004) · Current Opinion in Neurology · doi:10.1097/00019052-200404000-00003 · Cited by 129
Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model
Lockrow, J., Prakasam, A., Huang, P., Bimonte-Nelson, H., Sambamurti, K., & Granholm, A.-C. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2008.11.021 · Cited by 123
Cenini, G., Dowling, A. L. S., Beckett, T. L., Barone, E., Mancuso, C., Murphy, M. P., LeVine, H., Lott, I. T., Schmitt, F. A., Butterfield, D. A., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.001 · Cited by 123
“), Aβ accumulation in DS is associated with enhanced formation of reactive oxygen species (ROS) in neurons leading to premature neuronal dysfunction and death as a consequence of increased oxidative stress [11, 37, 50].”
Oxidative Stress and Mitochondrial Dysfunction in Down Syndrome
Pagano, G., & Castello, G. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_22 · Cited by 135
Cannabinoids Protect Cells from Oxidative Cell Death: A Receptor-Independent Mechanism
Chen, Y., & Buck, J. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39301-2 · Cited by 126
“Exogenous small-molecule antioxidants also have been shown to effectively prevent oxidative cell death in cultured cells (Busciglio and Yankner, 1995; Johnson et al., 1996; Nakao et al., 1996; Hampson et al., 1998).”
BackgroundFree radicals in Alzheimer’s disease
Retz, W., Gsell, W., Münch, G. W., Rösler, M., & Riederer, P. F. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-7508-8_22 · Cited by 129
Bordi, M., Darji, S., Sato, Y., Mellén, M., Berg, M. J., Kumar, A., Jiang, Y., & Nixon, R. A. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1752-5 · Cited by 124
Liu, H., Wang, P., Song, W., & Sun, X. (2009) · The FASEB Journal · doi:10.1096/fj.09-134296 · Cited by 124
Kim, S. H., Vlkolinský, R., Cairns, N. J., & Lübec, G. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000661 · Cited by 124
Berger, R. E., & Garnier, Y. (2000) · Journal of Perinatal Medicine · doi:10.1515/jpm.2000.034 · Cited by 135
“DNAfragmentation in neurons illustrated by the TUNELmethod [40].”
InfluentialReactive Oxygen Species Participate in the Control of Mouse Embryonic Cell Death
Vidal, E. S., Lomelı́, H., Castro‐Obregón, S., Cuervo, R., Escalante‐Alcalde, D., & Covarrubias, L. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3828 · Cited by 123
Garcia, O., Torres, M., Helguera, P., Coskun, P., & Busciglio, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014200 · Cited by 122
“For example, APP secretory deficits in DS astrocytes are directly linked to impaired mitochondrial metabolism and abnormal secretory function [22], and increased apoptosis of DS neurons can be prevented by antioxidants [40].”
BackgroundSelf-citationNeurogenesis impairment: An early developmental defect in Down syndrome
Stagni, F., Giacomini, A., Emili, M., Guidi, S., & Bartesaghi, R. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.07.026 · Cited by 120
“increased levels of intracellular reactive oxygen species and lipid peroxidation, preceding neuronal death, which can be prevented by antioxidants [84].”
Gardiner, K. (2014) · Drug Design, Development and Therapy · doi:10.2147/dddt.s51476 · Cited by 111
“Cortical neurons derived from DS fetal brains show elevated levels of reactive oxygen species, and survival is enhanced by treatment with antioxidants.(92) Several Hsa21 genes, among them SOD1, BACH1, ETS2, and S100B, are known to contribute to the regulation of oxidative stress when overexpressed.”
Oxidative stress‐mediated down‐regulation of bcl‐2 promoter in hippocampal neurons
Pugazhenthi, S., Nesterova, A., Jambal, P., Audesirk, G., Kern, M., Cabell, L., Eves, E., Rosner, M. R., Boxer, L. M., & Reusch, J. E. ‐. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01606.x · Cited by 119
Down syndrome, drug metabolism and chromosome 21
Taub, J. W., & Ge, Y. (2004) · Pediatric Blood & Cancer · doi:10.1002/pbc.20092 · Cited by 119
Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome
Shukkur, E. A., Shimohata, A., Akagi, T., Yu, W., Yamaguchi, M., Murayama, M., Chui, D., Takeuchi, T., Amano, K., Subramhanya, K. H., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl211 · Cited by 118
“Similarly, altered free radical metabolism and impaired mitochondrial function are linked to neuronal degeneration of DS cortical neurons in culture (8,9) and may be associated with both mental retardation and AD pathology in person with DS.”
BackgroundShichiri, M., Yoshida, Y., Ishida, N., Hagihara, Y., Iwahashi, H., Tamai, H., & Niki, E. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.023 · Cited by 133
Accumulation of Mitochondrial DNA Damage in Keratoconus Corneas
Atilano, S. R., Coskun, P. E., Chwa, M., Jordan, N., Reddy, V., Le, K., Wallace, D. C., & Kenney, M. C. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-1395 · Cited by 127
Early Glycoxidation Damage in Brains from Down's Syndrome
Odetti, P. R., Angelini, G., Dapino, D., Zaccheo, D., Garibaldi, S., Dagna-Bricarelli, F., Piombo, G., Perry, G. L., Smith, M. A., Traverso, N., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8186 · Cited by 118
Regulator of Calcineurin 1 (RCAN1) Facilitates Neuronal Apoptosis through Caspase-3 Activation
Sun, X., 孙, 秀., Wu, Y., 吴, 伊., Chen, B., Zhang, Z., Zhou, W., Tong, Y., 童, 贻., Yuan, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.177519 · Cited by 115
Healthy and abnormal development of the prefrontal cortex
Spencer-Smith, M., & Anderson, V. (2009) · Developmental Neurorehabilitation · doi:10.3109/17518420903090701 · Cited by 114
“Foetuses with Down syndrome have experienced high rates of apoptosis [114], which is thought to account for intellectual impairment associated with this syndrome.”
BackgroundEsposito, G., Imitola, J., Lu, J., De Filippis, D., Scuderi, C., Ganesh, V. S., Folkerth, R., Hecht, J., Shin, S., Iuvone, T., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm322 · Cited by 115
“Primary cortical neurons from gestational 16–18 week fetal DS brain fail to survive long-term in comparison to normal cultures, even in the presence of serum with survival factors (19).”
BackgroundInfluentialPhospholipid composition and levels are altered in down syndrome brain
Murphy, E. J., Schapiro, M. B., Rapoport, S. I., & Shetty, H. U. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02205-8 · Cited by 114
Grace, E. A., & Busciglio, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-02-00493.2003 · Cited by 113
“Neuronal viability was evaluated using a propidium iodide exclusion assay as described previously (Busciglio and Yankner, 1995; Grace et al., 2002).”
BackgroundMethodInfluentialSelf-citationNeuronal RNA Oxidation in Alzheimer's Disease and Down's Syndrome
Nunomura, A., Perry, G. L., Hirai, K., Aliev, G., Takeda, A., Chiba, S., & Smith, M. A. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07855.x · Cited by 112
Anderson, C. P., Tsai, J. M., Meek, W. E., Liu, R.-M., Tang, Y., Forman, H. J., & Reynolds, C. P. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4303 · Cited by 113
Hall, J., Prabhakar, S., Balaj, L., Lai, C. P., Cerione, R. A., & Breakefield, X. O. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0309-0 · Cited by 107
“Parkinson’s disease (PD) is a neurodegenerative disorder characterized by microglia stimulation, swelling of the brain, and the release of neurotoxic reactive oxygen species (ROS) (Mcgeer et al. 1988; Busciglio and Yankner 1995; Ebadi et al. 1996; Wu et al. 2003).”
BackgroundDown Syndrome: Advances in Molecular Biology and the Neurosciences
CAPONE, G. T. (2001) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200102000-00007 · Cited by 110
“Such findings are consistent with increased oxidative DNA damage in vivo and suggest that chronic oxidative injury constitutes a risk factor for subsequent neuronal death in aged individuals with DS.(97,186) Chromosome 21, Inflammatory Mechanisms, and Alzheimer's Neuropathology”
BackgroundYang, Y., Liú, D., Wu, J., Chen, Y., & Wang, S. (2011) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2011.08.026 · Cited by 114
Leo, M. E. D., Borrello, S., Passantino, M., Palazzotti, B., Mordente, A., Daniele, A., Filippini, V., Galeotti, T., & Masullo, C. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00469-8 · Cited by 108
Chromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer's disease
Thomas, P., & Fenech, M. (2007) · Mutagenesis · doi:10.1093/mutage/gem044 · Cited by 107
Wemmie, J. A., Steggerda, S. M., & Moye-Rowley, W. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7908 · Cited by 107
Bar-Peled, O., Korkotian, E., Segal, M., & Groner, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8530 · Cited by 107
Oxidative stress in neurodegeneration and available means of protection
Fatokun, A. A., Stone, T. W., & Smith, R. A. (2008) · Frontiers in bioscience · doi:10.2741/2926 · Cited by 109
de Haan, J. B., Crack, P. J., Flentjar, N., Iannello, R. C., Hertzog, P. J., & Kola, I. (2003) · Redox Report · doi:10.1179/135100003125001378 · Cited by 102
Metallothionein polymorphisms in pathological processes
Raudenská, M., Gumulec, J., Podlaha, O., Sztalmachová, M., Babula, P., Eckschlager, T., Adam, V., Kizek, R., & Masařík, M. (2013) · Metallomics · doi:10.1039/c3mt00132f · Cited by 111
Tumorigenesis in Down's syndrome: big lessons from a small chromosome
Nižetić, D., & Groet, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3355 · Cited by 115
Myeloid Leukemia in Down Syndrome
Khan, I., Malinge, S., & Crispino, J. D. (2011) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v16.i1-2.40 · Cited by 102
Ellis, J. M., Tan, H. K., Gilbert, R. E., Muller, D. P. R., Henley, W., Moy, R., Pumphrey, R., Ani, C., Davies, S., Edwards, V., et al. (2008) · BMJ · doi:10.1136/bmj.39465.544028.ae · Cited by 102
“Secondly, cortical neurones from fetuses with Down’s syndrome have an increased concentration of intracellular oxygen derived free radicals and increased lipid peroxidation compared with controls.”
BackgroundSawada, M., Nakashima, S., Kiyono, T., Nakagawa, M., Yamada, J., Yamakawa, H., Banno, Y., Shinoda, J., Nishimura, Y., Nozawa, Y., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204207 · Cited by 109
“In contrast, induction of apoptosis is inhibited by antioxidants and by superoxide dismutase or catalase (Busciglio and Yankner, 1995; Moreno-Manzano et al., 2000; Huang et al., 2000).”
BackgroundMelatonin cytotoxicity in human leukemia cells: relation with its pro‐oxidant effect
Büyükavcı, M., Özdemir, Ö., Buck, S., Stout, M., Ravindranath, Y., & Savaşan, S. (2006) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2005.00389.x · Cited by 99
Piccoli, C., Izzo, A., Scrima, R., Bonfiglio, F., Manco, R., Negri, R., Quarato, G., Cela, O., Ripoli, M., Prisco, M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds529 · Cited by 95
Qualitative and quantitative estimates of apoptosis from birth to senescence in the rat brain
White, L. D., & Barone, S. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400816 · Cited by 111
“Apoptosis is believed to underlie the pathogenesis of a number of human neurodegenerative diseases, including Alzheimer's disease (reviewed in(45,46)), Huntington's disease,(47) Parkinson's disease,(48) and Down's syndrome.(49) In normal human development, cortical cell number is estimated to peak at 28 weeks of gesta…”
BackgroundHead, E., Silverman, W., Patterson, D., & Lott, I. T. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/412536 · Cited by 93
“Oxidative damage has been extensively studied in people with DS, because a significant number ( > 10) of genes encoding proteins relevant to oxidative damage [40–42] and ROS production located on chromosome 21 [43].”
Mitochondria as pharmacological targets in Down syndrome
Valenti, D., Braidy, N., Rasmo, D. D., Signorile, A., Rossi, L., Atanasov, A. G., Volpicella, M., Henrion‐Caude, A., Nabavi, S. M., & Vacca, R. A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.014 · Cited by 104
“Upregulation in ROS generation and mitochondrial dysfunction has been identified in DS cells during early development and commencing of embryonic life [116].”
BackgroundReactive Oxygen Species as Mediators of Photoreceptor Apoptosisin Vitro
Carmody, R. J., McGowan, A. J., & Cotter, T. G. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4421 · Cited by 98
Down syndrome: Neurobiological alterations and therapeutic targets
Vacca, R. A., Bawari, S., Valenti, D., Tewari, D., Nabavi, S. F., Shirooie, S., Sah, A. N., Volpicella, M., Braidy, N., & Nabavi, S. M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.01.001 · Cited by 90
Wolvetang, E. J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.3.247 · Cited by 99
“In addition to fibroblasts, other Down syndrome tissues shown to have elevated apoptosis, namely thymus (data not shown) and neurons (18) were also demonstrated to exhibit elevated levels of ETS2, p53 and reduced BCL2 (Fig.”
BackgroundResultNitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059
Green, A. R., Ashwood, T. J., Odergren, T., & Jackson, D. M. (2003) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.07.003 · Cited by 98
Zhang, L., Zhao, B., Yew, D. T. W., Kusiak, J. W., & Roth, G. S. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6698 · Cited by 101
Chrast, R. (2000) · Genome Research · doi:10.1101/gr.10.12.2006 · Cited by 100
Perluigi, M., di Domenico, F., Fiorini, A., Cocciolo, A., Giorgi, A., Foppoli, C., Butterfield, D. A., Giorlandino, M., Giorlandino, C., Eugenia Schininà, M., et al. (2011) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201000121 · Cited by 97
“In addition, DS neurons exhibit a consistent increase in intracellular ROS and elevated levels of lipid peroxidation that precede neuronal death [26].”
BackgroundReactive Oxygen and Nitrogen Species Regulate Mitochondrial Ca2+ Homeostasis and Respiration
Richter, C. (1997) · Bioscience Reports · doi:10.1023/a:1027387301845 · Cited by 96
Mechanisms by which metals promote events connected to neurodegenerative diseases
Campbell, A., Smith, M. A., Sayre, L. M., Bondy, S. C., & Perry, G. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00455-5 · Cited by 96
“Furthermore, in Down’s syndrome, which leads to early onset of the pathological changes of AD, evidence of oxidative stress is found long before neuropathological changes, even at the fetal stage [22,77–79].”
BackgroundChang, K. T., & Min, K. (2005) · Nature Neuroscience · doi:10.1038/nn1564 · Cited by 100
Molecular changes in fetal Down syndrome brain
Engidawork, E., & Lubec, G. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01614.x · Cited by 95
Metadata
- Authors
- Busciglio, J., & Yankner, B. A.
- Affiliations
- Boston Children's Hospital (US)
- Venue
- Nature
- Published
- 1995-12
- Volume
- 378
- Issue
- 6559
- Pages
- 776-779
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1992689843
- Cited by
- 741
- References
- 26
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 6 · 2023: 16 · 2022: 13 · 2021: 13 · 2020: 16 · 2019: 19 · 2018: 16 · 2017: 15 · 2016: 21 · 2015: 21 · 2014: 25 · 2013: 30 · 2012: 32
- FWCI
- 57.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- Down syndrome, neuronal apoptosis, reactive oxygen species, lipid peroxidation, cortical neurons, neurodegeneration, radical scavengers, catalase, Alzheimer's disease, intellectual disability, oxidative stress
- MeSH terms
- Alzheimer Disease, Antioxidants, Cell Differentiation, Cells, Cultured, Cerebral Cortex, Cycloheximide, Dactinomycin, Down Syndrome, Fluoresceins, Humans, Nerve Degeneration, Neurons, Lipid Peroxidation, Free Radical Scavengers, Apoptosis, Reactive Oxygen Species, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.